pharma · Chronic Spontaneous Urticaria · Asthma
Novartis India
Novartis Pharmaceuticals
Novartis Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Chronic Spontaneous Urticaria, Asthma, Systemic Lupus Erythematosus, Breast Cancer, Multiple Sclerosis. NovaP
Mumbai, IN HQ
1996 Founded
2,240 Employees
NMPA registrant Type
Company details
- Status
- Public
- HQ
- Mumbai, IN
- Founded
- 1996
- Employees
- 2,240
- Programs
- 341
- Drugs
- 317
- Patents
- 0
CAAA617H12101
Phase 2 · other · Metastatic neuroendocrine prostate cancer
CAAA617H12101 for Metastatic neuroendocrine prostate cancer is a Phase 2 program (other) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code CAAA617H12101
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 2
- Modality
- other
- Indication
- Metastatic neuroendocrine prostate cancer
- Status
- active
- Trials
- 1